SCHEMBL21189407

SCHEMBL21189407

COC(=O)N[C@H]1CCOc2c(C(=O)Nc3ccccc3)cccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CREBBP Q92793 4/20 0.42
BRD4 O60885 3/20 0.42
ALDH1A1 P00352 3/20 0.40
HPGD P15428 3/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 2/20 0.39
KCNK3 O14649 2/20 0.39
KCNK9 Q9NPC2 2/20 0.39
KMT2A Q03164 5/20 0.39
MEN1 O00255 4/20 0.38
TP53 P04637 2/20 0.38
KDM4E B2RXH2 1/20 0.38
HTT P42858 1/20 0.38
HSD17B10 Q99714 1/20 0.38
NPC1 O15118 1/20 0.38
MAPT P10636 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21189281 0.90 LMNA (0.41) ALDH1A1RAB9ASMN1; SMN2LMNAKMT2A
SCHEMBL21189185 0.89 FADS1 (0.45) ALDH1A1HPGDRAB9ASMN1; SMN2LMNA
SCHEMBL19973910 0.89 HPGD (0.43) CREBBPBRD4ALDH1A1HPGDLMNA
SCHEMBL19973908 0.89 HPGD (0.43) CREBBPBRD4ALDH1A1HPGDLMNA
SCHEMBL21189350 0.87 TRPV1 (0.38) BRD4ALDH1A1RAB9ASMN1; SMN2KMT2A
SCHEMBL21189267 0.86 AKR1C3 (0.38) ALDH1A1HPGDRAB9ASMN1; SMN2TP53
SCHEMBL21189489 0.86 HTT (0.47) KMT2AHTTTSHR
SCHEMBL19973620 0.86 RXFP1 (0.51) SMN1; SMN2MAPT
SCHEMBL19973644 0.86 TRPV1 (0.38) CREBBPBRD4KMT2AMEN1KDM4E
SCHEMBL19973646 0.86 TRPV1 (0.38) CREBBPBRD4KMT2AMEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US disclosed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME CBX8, HAVCR2, HCCS CREBBP 864/4885BRD4 7/4885ALDH1A1 3241/4885
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same CBX8, HAVCR2, HCCS CREBBP 864/4885BRD4 7/4885ALDH1A1 3241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.